Stanford neuromodulation therapy for treatment‐resistant depression: a randomized controlled trial confirming efficacy, and an <scp>EEG</scp> study providing insight into mechanism of action and a potentially predictive biomarker of efficacy
- DOI
- 10.1002/wps.70032
- Published
- 2026-01-14
- Container
- World Psychiatry
- Publisher
- Wiley
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1002/wps.70032,
title = {Stanford neuromodulation therapy for treatment‐resistant depression: a randomized controlled trial confirming efficacy, and an
<scp>EEG</scp>
study providing insight into mechanism of action and a potentially predictive biomarker of efficacy},
author = {Ian H. Kratter and Christopher W. Austelle and Jennifer I. Lissemore and Masataka Wada and Andrew Geoly and Anna Chaiken and Irakli Kaloiani and Noriah Johnson and Stephanie Wan and Lena Kozyr and Ethan Makarewycz and Brendan Wong and Malvika Sridhar and Flint M. Espil and Nick Bassano and Bora Kim and Jarrod Ehrie and Adi Maron‐Katz and Claudia Tischler and Romina Nejad and Jean‐Marie Batail and Angela L. Phillips and Eleanor J. Cole and Tiffany J. Ford and Brandon S. Bentzley and Booil Jo and Alan F. Schatzberg and David Spiegel and Cammie Rolle and Gregory L. Sahlem and Nolan R. Williams},
year = {2026},
journal = {World Psychiatry},
doi = {10.1002/wps.70032},
url = {https://doi.org/10.1002/wps.70032}
}RIS
TY - JOUR
TI - Stanford neuromodulation therapy for treatment‐resistant depression: a randomized controlled trial confirming efficacy, and an
<scp>EEG</scp>
study providing insight into mechanism of action and a potentially predictive biomarker of efficacy
AU - Ian H. Kratter
AU - Christopher W. Austelle
AU - Jennifer I. Lissemore
AU - Masataka Wada
AU - Andrew Geoly
AU - Anna Chaiken
AU - Irakli Kaloiani
AU - Noriah Johnson
AU - Stephanie Wan
AU - Lena Kozyr
AU - Ethan Makarewycz
AU - Brendan Wong
AU - Malvika Sridhar
AU - Flint M. Espil
AU - Nick Bassano
AU - Bora Kim
AU - Jarrod Ehrie
AU - Adi Maron‐Katz
AU - Claudia Tischler
AU - Romina Nejad
AU - Jean‐Marie Batail
AU - Angela L. Phillips
AU - Eleanor J. Cole
AU - Tiffany J. Ford
AU - Brandon S. Bentzley
AU - Booil Jo
AU - Alan F. Schatzberg
AU - David Spiegel
AU - Cammie Rolle
AU - Gregory L. Sahlem
AU - Nolan R. Williams
PY - 2026
JO - World Psychiatry
DO - 10.1002/wps.70032
UR - https://doi.org/10.1002/wps.70032
ER - APA
Kratter, I. H., Austelle, C. W., Lissemore, J. I., Wada, M., Geoly, A., Chaiken, A., Kaloiani, I., Johnson, N., Wan, S., Kozyr, L., Makarewycz, E., Wong, B., Sridhar, M., Espil, F. M., Bassano, N., Kim, B., Ehrie, J., Maron‐Katz, A., Tischler, C., Nejad, R., Batail, J., Phillips, A. L., Cole, E. J., Ford, T. J., Bentzley, B. S., Jo, B., Schatzberg, A. F., Spiegel, D., Rolle, C., Sahlem, G. L., & Williams, N. R. (2026). Stanford neuromodulation therapy for treatment‐resistant depression: a randomized controlled trial confirming efficacy, and an <scp>EEG</scp> study providing insight into mechanism of action and a potentially predictive biomarker of efficacy. World Psychiatry. https://doi.org/10.1002/wps.70032
Source records
- crossref · retrieved 2026-09-27T12:13:28.147Z